Advertisement Pharmaceutical Business review - Page 112 of 5257 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
January 19, 2026

FDA grants Novartis’ ianalumab breakthrough therapy status for Sjögren’s disease

Novartis has announced that the US Food and Drug Administration (FDA) has granted breakthrough therapy designation to ianalumab, a treatment for Sjögren’s disease, the second most prevalent rheumatic autoimmune condition.

Continue
The latest FDA recognition is supported by positive results from several studies, including two replicate Phase III trials. Credit: Motortion Films / Shutterstock.com.
January 19, 2026

AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy

AbelZeta will receive up to $630m from AstraZeneca, including upfront payments and milestone fees for GPC3. Credit: grandbrothers / Shutterstock.com.
January 16, 2026

InterAx and Alveus collaborate on small-molecule metabolic treatment

The collaboration combines InterAx Biotech’s Deep Signal discovery platform with Alveus Therapeutics’ R&D capabilities in metabolic diseases. Credit: Sai Thaw Kyar / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Agenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal
  2. BD invests $110m to expand US prefillable syringe production
  3. Fortress Biotech receives FDA approval for Zycubo to treat Menkes disease
  4. SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody
  5. Atara receives FDA complete response letter for Ebvallo BLA application

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography